Type 2 Diabetes Increases Risk for Hepatic Decompensation, HCC in NAFLD
The likelihood of developing hepatic decompensation and hepatocellular carcinoma is higher among patients with NAFLD and type 2 diabetes.
Source: endocrinologyadvisor.com
Stay updated with breaking news from Cochrane Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The likelihood of developing hepatic decompensation and hepatocellular carcinoma is higher among patients with NAFLD and type 2 diabetes.